283 related articles for article (PubMed ID: 23187125)
1. Endothelial epsin deficiency decreases tumor growth by enhancing VEGF signaling.
Pasula S; Cai X; Dong Y; Messa M; McManus J; Chang B; Liu X; Zhu H; Mansat RS; Yoon SJ; Hahn S; Keeling J; Saunders D; Ko G; Knight J; Newton G; Luscinskas F; Sun X; Towner R; Lupu F; Xia L; Cremona O; De Camilli P; Min W; Chen H
J Clin Invest; 2012 Dec; 122(12):4424-38. PubMed ID: 23187125
[TBL] [Abstract][Full Text] [Related]
2. Genetic reduction of vascular endothelial growth factor receptor 2 rescues aberrant angiogenesis caused by epsin deficiency.
Tessneer KL; Pasula S; Cai X; Dong Y; McManus J; Liu X; Yu L; Hahn S; Chang B; Chen Y; Griffin C; Xia L; Adams RH; Chen H
Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):331-337. PubMed ID: 24311377
[TBL] [Abstract][Full Text] [Related]
3. Selective Targeting of a Novel Epsin-VEGFR2 Interaction Promotes VEGF-Mediated Angiogenesis.
Rahman HNA; Wu H; Dong Y; Pasula S; Wen A; Sun Y; Brophy ML; Tessneer KL; Cai X; McManus J; Chang B; Kwak S; Rahman NS; Xu W; Fernandes C; Mcdaniel JM; Xia L; Smith L; Srinivasan RS; Chen H
Circ Res; 2016 Mar; 118(6):957-969. PubMed ID: 26879230
[TBL] [Abstract][Full Text] [Related]
4. VEGFR3 Modulates Vascular Permeability by Controlling VEGF/VEGFR2 Signaling.
Heinolainen K; Karaman S; D'Amico G; Tammela T; Sormunen R; Eklund L; Alitalo K; Zarkada G
Circ Res; 2017 Apr; 120(9):1414-1425. PubMed ID: 28298294
[TBL] [Abstract][Full Text] [Related]
5. Endothelial epsins as regulators and potential therapeutic targets of tumor angiogenesis.
Song K; Wu H; Rahman HN; Dong Y; Wen A; Brophy ML; Wong S; Kwak S; Bielenberg DR; Chen H
Cell Mol Life Sci; 2017 Feb; 74(3):393-398. PubMed ID: 27572288
[TBL] [Abstract][Full Text] [Related]
6. Are epsins a therapeutic target for tumor angiogenesis?
Klauber-Demore N
J Clin Invest; 2012 Dec; 122(12):4341-3. PubMed ID: 23187137
[TBL] [Abstract][Full Text] [Related]
7. R-Ras protein inhibits autophosphorylation of vascular endothelial growth factor receptor 2 in endothelial cells and suppresses receptor activation in tumor vasculature.
Sawada J; Li F; Komatsu M
J Biol Chem; 2015 Mar; 290(13):8133-45. PubMed ID: 25645912
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic efficacy of a synthetic epsin mimetic peptide in glioma tumor model: uncovering multiple mechanisms beyond the VEGF-associated tumor angiogenesis.
Dong J; Saunders D; Silasi-Mansat R; Yu L; Zhu H; Lupu F; Towner R; Dong Y; Chen H
J Neurooncol; 2018 May; 138(1):17-27. PubMed ID: 29357089
[TBL] [Abstract][Full Text] [Related]
9. Epsin deficiency promotes lymphangiogenesis through regulation of VEGFR3 degradation in diabetes.
Wu H; Rahman HNA; Dong Y; Liu X; Lee Y; Wen A; To KH; Xiao L; Birsner AE; Bazinet L; Wong S; Song K; Brophy ML; Mahamud MR; Chang B; Cai X; Pasula S; Kwak S; Yang W; Bischoff J; Xu J; Bielenberg DR; Dixon JB; D'Amato RJ; Srinivasan RS; Chen H
J Clin Invest; 2018 Aug; 128(9):4025-4043. PubMed ID: 30102256
[TBL] [Abstract][Full Text] [Related]
10. Epsins in vascular development, function and disease.
Bhattacharjee S; Lee Y; Zhu B; Wu H; Chen Y; Chen H
Cell Mol Life Sci; 2021 Feb; 78(3):833-842. PubMed ID: 32930806
[TBL] [Abstract][Full Text] [Related]
11. Motif mimetic of epsin perturbs tumor growth and metastasis.
Dong Y; Wu H; Rahman HN; Liu Y; Pasula S; Tessneer KL; Cai X; Liu X; Chang B; McManus J; Hahn S; Dong J; Brophy ML; Yu L; Song K; Silasi-Mansat R; Saunders D; Njoku C; Song H; Mehta-D'Souza P; Towner R; Lupu F; McEver RP; Xia L; Boerboom D; Srinivasan RS; Chen H
J Clin Invest; 2015 Dec; 125(12):4349-64. PubMed ID: 26571402
[TBL] [Abstract][Full Text] [Related]
12. Integrin alpha x stimulates cancer angiogenesis through PI3K/Akt signaling-mediated VEGFR2/VEGF-A overexpression in blood vessel endothelial cells.
Wang J; Yang L; Liang F; Chen Y; Yang G
J Cell Biochem; 2019 Feb; 120(2):1807-1818. PubMed ID: 30873824
[TBL] [Abstract][Full Text] [Related]
13. Loss of osteoglycin promotes angiogenesis in limb ischaemia mouse models via modulation of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 signalling pathway.
Wu QH; Ma Y; Ruan CC; Yang Y; Liu XH; Ge Q; Kong LR; Zhang JW; Yan C; Gao PJ
Cardiovasc Res; 2017 Jan; 113(1):70-80. PubMed ID: 28069703
[TBL] [Abstract][Full Text] [Related]
14. Myeloid-Specific Deletion of Epsins 1 and 2 Reduces Atherosclerosis by Preventing LRP-1 Downregulation.
Brophy ML; Dong Y; Tao H; Yancey PG; Song K; Zhang K; Wen A; Wu H; Lee Y; Malovichko MV; Sithu SD; Wong S; Yu L; Kocher O; Bischoff J; Srivastava S; Linton MF; Ley K; Chen H
Circ Res; 2019 Feb; 124(4):e6-e19. PubMed ID: 30595089
[TBL] [Abstract][Full Text] [Related]
15. Cross-talk between leukemic and endothelial cells promotes angiogenesis by VEGF activation of the Notch/Dll4 pathway.
Zhang J; Ye J; Ma D; Liu N; Wu H; Yu S; Sun X; Tse W; Ji C
Carcinogenesis; 2013 Mar; 34(3):667-77. PubMed ID: 23239744
[TBL] [Abstract][Full Text] [Related]
16. Epsin Endocytic Adaptor Proteins in Angiogenic and Lymphangiogenic Signaling.
Cowan DB; Wu H; Chen H
Cold Spring Harb Perspect Med; 2024 Jan; 14(1):. PubMed ID: 37217282
[TBL] [Abstract][Full Text] [Related]
17. The impact of the receptor binding profiles of the vascular endothelial growth factors on their angiogenic features.
Nieminen T; Toivanen PI; Rintanen N; Heikura T; Jauhiainen S; Airenne KJ; Alitalo K; Marjomäki V; Ylä-Herttuala S
Biochim Biophys Acta; 2014 Jan; 1840(1):454-63. PubMed ID: 24112971
[TBL] [Abstract][Full Text] [Related]
18. Novel noncanonical regulation of soluble VEGF/VEGFR2 signaling by mechanosensitive ion channel TRPV4.
Kanugula AK; Adapala RK; Midha P; Cappelli HC; Meszaros JG; Paruchuri S; Chilian WM; Thodeti CK
FASEB J; 2019 Jan; 33(1):195-203. PubMed ID: 29957061
[TBL] [Abstract][Full Text] [Related]
19. Ginkgo biloba exocarp extracts inhibits angiogenesis and its effects on Wnt/β-catenin-VEGF signaling pathway in Lewis lung cancer.
Han D; Cao C; Su Y; Wang J; Sun J; Chen H; Xu A
J Ethnopharmacol; 2016 Nov; 192():406-412. PubMed ID: 27649680
[TBL] [Abstract][Full Text] [Related]
20. DDA suppresses angiogenesis and tumor growth of colorectal cancer in vivo through decreasing VEGFR2 signaling.
Huang SW; Lien JC; Kuo SC; Huang TF
Oncotarget; 2016 Sep; 7(39):63124-63137. PubMed ID: 27517319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
